Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection

PLoS ONE - United States
doi 10.1371/journal.pone.0020029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Serum Metabolomics as a Novel Diagnostic Approach for Pancreatic Cancer

Metabolomics
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

Identification of the Peanut-Agglutinin Binding Pancreatic Cancer Serum Marker in Pancreatic Tissue Extracts

British Journal of Cancer
Cancer ResearchOncology
1990English

A Systematic Review of Serum Autoantibodies as Biomarkers for Pancreatic Cancer Detection

Oncotarget
Oncology
2016English

A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2013English

Serum Sphingolipids Level as a Novel Potential Marker for Early Detection of Human Myocardial Ischaemic Injury

Frontiers in Physiology
Physiology
2013English

A Novel Biophysical Based Marker With Multilevel, Multiparameter Expression for Early Stage Cancer Detection.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2019English

Identification of PSME3 as a Novel Serum Tumor Marker for Colorectal Cancer by Combining Two-Dimensional Polyacrylamide Gel Electrophoresis With a Strictly Mass Spectrometry-Based Approach for Data Analysis

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2006English

HYAL2 Methylation in Peripheral Blood as a Potential Marker for the Detection of Pancreatic Cancer – A Case Control Study

Oncotarget
Oncology
2017English

Serum Anti-P53 Antibody as a Tumour Marker for Colorectal Cancer Screening

ecancermedicalscience
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy